Please login to the form below

Not currently logged in
Email:
Password:

Allergy research honoured

New global research award recognises contributions to the treatment of allergies

The World Allergy Organisation (WAO) and allergy immunotherapy company, ALK-AbellÛ, have come together to set up a biennial, worldwide allergy research award to be presented for the first time at the World Allergy Congress (WAC), taking place in Bangkok from 2-6 December 2007.

The WAO Henning L¯wenstein Research Award will honour a research scientist who has demonstrated excellence in the field of allergy.

The WAO is an international umbrella organization, founded in 1951, whose members consist of 74 regional and national allergology and clinical immunology societies from around the world.

Henning L¯wenstein worked on research into new methods for allergen standardisation in the 1970s, and has contributed significantly to allergy research in the intervening years. He is the former executive vice-president of research at ALK-AbellÛ and a member of this new awardís international scientific board.

Before this collaboration ALK-AbellÛ had bestowed a research award annually since 1999, when it was introduced in celebration of L¯wensteinís 25th year at the company.

Applicants for the new award will be evaluated on their research contributions in terms of of potential significance for the future understanding and treatment of allergy. The recipient will receive EUR 20,000 and a travel grant to attend the congress and awards dinner in Bangkok.

Dr Michael A Kaliner, president of the WAO said: ìWAOís mission is to be a global resource and advocate in the field of allergy, advancing excellence in clinical care, education, research and training. By presenting an important scientific award in collaboration with ALK-AbellÛ, we hope to encourage more scientists to focus on this important scientific area.î

Dr Henrik Jacobi executive vice-president of R&D at ALK-AbellÛ added: ìWe believe that further research on the nature and treatment of allergies will lead the way for future achievements, to the benefit of people with allergies all over the world.î

Applications will be evaluated by an international scientific board comprising: Rob Aalberse, from the Netherlands; G Walter Canonica, Italy; Stephen Durham, UK; Patrick Holt, Australia; Allen Kaplan, US; Henning L¯wenstein, Denmark; and Ulrich Wahn, Germany.

The deadline for entry is 30 June 2007. Scientists are invited to view competition guidelines, as well as to submit their entries at www.alk-abello.com/award.

19th June 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health Insight

Cello Health Insight is the global market research arm of Cello Health. With 35 years’ sector experience, we specialise in...

Latest intelligence

image 1
Redefining communications excellence
How to be heard in today’s multichannel, multistakeholder, multimedia world...
AZ Campus
AstraZeneca: building a new ‘open innovation’ pharma company
The construction of its new HQ has suffered some serious delays, but new R&D and commercial success are lifting AstraZeneca’s prospects...
Erik Nordkamp
In conversation with Pfizer’s Erik Nordkamp
Pfizer’s UK general manager talks to PME about the NHS at 70, the potential of pharma partnerships and some lessons from Europe...

Infographics